PFKFB3 Inhibitor 3PO Reduces Cardiac Remodeling after Myocardial Infarction by Regulating the TGF-β1/SMAD2/3 Pathway

Adverse cardiac remodeling, including cardiac fibrosis, after myocardial infarction (MI) is a major cause of long-term heart failure. 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), an enzyme that regulates glucose metabolism, also plays an important role in various fibrotic and card...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Qian Yang, Xiao Zong, Lingfang Zhuang, Roubai Pan, Xierenayi Tudi, Qin Fan, Rong Tao
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2023-07-01
Schriftenreihe:	Biomolecules
Schlagworte:	PFKFB3 myocardial infarction (MI) cardiac remodeling cardiac fibroblast fibrosis
Online-Zugang:	https://www.mdpi.com/2218-273X/13/7/1072
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!